New Chairman for Actinogen Medical
2 March 2016 via Biotech Dispatch: Actinogen Medical (ASX:ACW) has announced the appointment of healthcare industry and venture capital veteran, Dr Geoff Brooke, as Chairman, effective 1 March.
The appointment adds significant life science and financial expertise to the Actinogen Board, with Dr Brooke having three decades international experience as the founder, lead investor and/or Chairman/Director of numerous healthcare companies with a realised value of more than $1.5 billion.
He was the Managing Director and Founder of leading life sciences venture capital firm, GBS Ventures – one of Asia Pacific’s premier investors in the healthcare space. He was responsible for GBS’s healthcare venture activity in the region and raised $450 million in venture and private equity funds, focused on biopharmaceuticals, medical devices and services.
Read more in Biotech Dispatch.